Lantheus to Present at the 2025 Truist Securities MedTech Conference
Rhea-AI Summary
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, LNTH declined 3.36%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
BEDFORD, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Brian Markison, Chief Executive Officer, will present at the 2025 Truist Securities MedTech Conference at 8:40 a.m. ET on Tuesday, June 17.
To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation.
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Sweden and Switzerland, Lantheus has been providing radiopharmaceutical solutions for nearly 70 years. For more information, visit www.lantheus.com.
Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com
Melissa Downs
Executive Director, External Communications
646-975-2533
media@lantheus.com
FAQ
When is Lantheus (LNTH) presenting at the 2025 Truist Securities MedTech Conference?
Who will represent Lantheus (LNTH) at the 2025 Truist Securities MedTech Conference?
How can investors access Lantheus's (LNTH) presentation at the Truist Securities Conference?
How long will the replay of Lantheus's (LNTH) presentation be available?
